메뉴 건너뛰기




Volumn 168, Issue 3, 2003, Pages 246-251

Compared protective effect of nasal immunoprophylaxis using a new human monoclonal IgM antibody, human polyclonal antibodies, F(ab′)2, amantadine, and zanamivir for prophylaxis of influenza A virus pneumonia in mice

Author keywords

[No Author keywords available]

Indexed keywords

AMANTADINE; HUMAN MONOCLONAL ANTIBODY; IMMUNOGLOBULIN F(AB')2 FRAGMENT; IMMUNOGLOBULIN M; MONOCLONAL ANTIBODY 3D2; MONOCLONAL ANTIBODY FAL11 2C3; MONOCLONAL ANTIBODY FAL8 1G4; POLYCLONAL ANTIBODY; UNCLASSIFIED DRUG; ZANAMIVIR;

EID: 0037341970     PISSN: 00264075     EISSN: None     Source Type: Journal    
DOI: 10.1093/milmed/168.3.246     Document Type: Article
Times cited : (6)

References (22)
  • 2
    • 0035370729 scopus 로고    scopus 로고
    • An outbreak of influenza a caused by imported virus in the United States. July 1999
    • Laurel VL, De Witt CC, Geddie YA, et al: An outbreak of influenza a caused by imported virus in the United States. July 1999. Clin Infect Dis 2001; 32: 1639-42.
    • (2001) Clin Infect Dis , vol.32 , pp. 1639-1642
    • Laurel, V.L.1    De Witt, C.C.2    Geddie, Y.A.3
  • 3
    • 0022381093 scopus 로고
    • Prevention from naturally acquired viral respiratory infection by interferon nasal spray
    • Saito H, Takenaka H, Yoshida S, et al: Prevention from naturally acquired viral respiratory infection by interferon nasal spray. Rhinology 1985; 23: 291-5.
    • (1985) Rhinology , vol.23 , pp. 291-295
    • Saito, H.1    Takenaka, H.2    Yoshida, S.3
  • 5
    • 0033590206 scopus 로고    scopus 로고
    • In vitro selection and characterisation of influenza B/Beijing/1/87 isolates with altered susceptibility to zanamivir
    • Barnett JM, Cadman A, Burrell FM, et al: In vitro selection and characterisation of influenza B/Beijing/1/87 isolates with altered susceptibility to zanamivir. Virology 1999; 265: 286-95.
    • (1999) Virology , vol.265 , pp. 286-295
    • Barnett, J.M.1    Cadman, A.2    Burrell, F.M.3
  • 7
    • 0000603293 scopus 로고
    • Production of rat monoclonal antibodies with the LOU rat nonsecreting IR983F myeloma cell line
    • Edited by Peeters H. Oxford, Pergamon
    • Bazin H: Production of rat monoclonal antibodies with the LOU rat nonsecreting IR983F myeloma cell line. In: Protides of the Biological Fluids, pp 615-18. Edited by Peeters H. Oxford, Pergamon, 1982.
    • (1982) Protides of the Biological Fluids , pp. 615-618
    • Bazin, H.1
  • 8
    • 0031766022 scopus 로고    scopus 로고
    • Characterization of influenza A/Hong Kong/156/97 (H5N1) virus in a mouse model and protective effect of zanamivir on H5N1 infection in mice
    • Gubareva LV, McCullers JA, Bethell RC, Webster RG: Characterization of influenza A/Hong Kong/156/97 (H5N1) virus in a mouse model and protective effect of zanamivir on H5N1 infection in mice. J Infect Dis 1998; 178: 1592-6.
    • (1998) J Infect Dis , vol.178 , pp. 1592-1596
    • Gubareva, L.V.1    McCullers, J.A.2    Bethell, R.C.3    Webster, R.G.4
  • 9
    • 0032729627 scopus 로고    scopus 로고
    • Chemoprophylaxis of influenza A virus infections with single doses of zanamivir demonstrates that zanamivir is cleared slowly from the respiratory tract
    • Fenton RJ, Morley PJ, Owens IJ, et al: Chemoprophylaxis of influenza A virus infections with single doses of zanamivir demonstrates that zanamivir is cleared slowly from the respiratory tract. Antimicrob Agents Chemother 1999; 43: 2642-7.
    • (1999) Antimicrob Agents Chemother , vol.43 , pp. 2642-2647
    • Fenton, R.J.1    Morley, P.J.2    Owens, I.J.3
  • 10
    • 0031008429 scopus 로고    scopus 로고
    • Prevention and treatment of influenza in immunocompromised patients
    • Hayden FG: Prevention and treatment of influenza in immunocompromised patients. Am J Med 1997; 102: 55-60.
    • (1997) Am J Med , vol.102 , pp. 55-60
    • Hayden, F.G.1
  • 11
    • 0034722755 scopus 로고    scopus 로고
    • Impact of zanamivir on antibiotic use for respiratory events following acute influenza in adolescents and adults
    • Kaiser L, Keene ON, Hammond JM, Elliott M, Hayden FG: Impact of zanamivir on antibiotic use for respiratory events following acute influenza in adolescents and adults. Arch Intern Med 2000; 160: 3234-40.
    • (2000) Arch Intern Med , vol.160 , pp. 3234-3240
    • Kaiser, L.1    Keene, O.N.2    Hammond, J.M.3    Elliott, M.4    Hayden, F.G.5
  • 12
    • 0034074146 scopus 로고    scopus 로고
    • Short-term treatment with zanamivir to prevent influenza: Results of a placebo-controlled study
    • Kaiser L, Henry D, Flack NP, Keene O, Hayden FG: Short-term treatment with zanamivir to prevent influenza: results of a placebo-controlled study. Clin Infect Dis 2000; 30: 587-9.
    • (2000) Clin Infect Dis , vol.30 , pp. 587-589
    • Kaiser, L.1    Henry, D.2    Flack, N.P.3    Keene, O.4    Hayden, F.G.5
  • 13
  • 14
    • 0033991487 scopus 로고    scopus 로고
    • Prevention and early treatment of influenza in healthy adults
    • Demicheli V, Jefferson T, Rivetti D, Deeks J: Prevention and early treatment of influenza in healthy adults. Vaccine 2000; 18: 957-1030.
    • (2000) Vaccine , vol.18 , pp. 957-1030
    • Demicheli, V.1    Jefferson, T.2    Rivetti, D.3    Deeks, J.4
  • 15
    • 0025241767 scopus 로고
    • Passively transferred monoclonal antibody to the M2 protein inhibits influenza A virus replication in mice
    • Treanor JJ, Tierney EL, Zebedee SL, Lamb RA, Murphy BR: Passively transferred monoclonal antibody to the M2 protein inhibits influenza A virus replication in mice. J Virol 1990; 64: 1375-7.
    • (1990) J Virol , vol.64 , pp. 1375-1377
    • Treanor, J.J.1    Tierney, E.L.2    Zebedee, S.L.3    Lamb, R.A.4    Murphy, B.R.5
  • 16
    • 0025859339 scopus 로고
    • Cross-protection against influenza A virus infection by passively transferred respiratory tract IgA antibodies to different hemagglutinin molecules
    • Tamura S, Funato H, Hirabayashi Y, et al: Cross-protection against influenza A virus infection by passively transferred respiratory tract IgA antibodies to different hemagglutinin molecules. Eur J Immunol 1991; 21: 1337-44.
    • (1991) Eur J Immunol , vol.21 , pp. 1337-1344
    • Tamura, S.1    Funato, H.2    Hirabayashi, Y.3
  • 17
    • 0028934157 scopus 로고
    • Amantadine-resistant influenza A in nursing homes: Identification of a resistant virus prior to drug use
    • Houck P, Hemphill M, LaCroix S, Hirsh D, Cox N: Amantadine-resistant influenza A in nursing homes: identification of a resistant virus prior to drug use. Arch Intern Med 1995; 155: 533-7.
    • (1995) Arch Intern Med , vol.155 , pp. 533-537
    • Houck, P.1    Hemphill, M.2    LaCroix, S.3    Hirsh, D.4    Cox, N.5
  • 18
    • 0026591279 scopus 로고
    • Comparison of IgA versus IgG monoclonal antibodies for passive immunization of the murine respiratory tract
    • Mazanec MB, Lamm ME, Lyn D, Portner A, Nedrud JG: Comparison of IgA versus IgG monoclonal antibodies for passive immunization of the murine respiratory tract. Virus Res 1992; 23: 1-12.
    • (1992) Virus Res , vol.23 , pp. 1-12
    • Mazanec, M.B.1    Lamm, M.E.2    Lyn, D.3    Portner, A.4    Nedrud, J.G.5
  • 19
    • 0030975069 scopus 로고    scopus 로고
    • A pulmonary influenza virus infection in SCID mice can be cured by treatment with hemagglutinin-specific antibodies that display very low virus-neutralizing activity in vitro
    • Mozdzanowska K, Furchner M, Washko G, Mozdzanowski J, Gerhard W: A pulmonary influenza virus infection in SCID mice can be cured by treatment with hemagglutinin-specific antibodies that display very low virus-neutralizing activity in vitro. J Virol 1997; 71: 4347-55.
    • (1997) J Virol , vol.71 , pp. 4347-4355
    • Mozdzanowska, K.1    Furchner, M.2    Washko, G.3    Mozdzanowski, J.4    Gerhard, W.5
  • 20
    • 0033079822 scopus 로고    scopus 로고
    • Treatment of influenza virus-infected SCID mice with nonneutralizing antibodies specific for the transmembrane proteins matrix 2 and neuraminidase reduces the pulmonary virus titer but fails to clear the infection
    • Mozdzanowska K, Maiese K, Furchner M, Gerhard W: Treatment of influenza virus-infected SCID mice with nonneutralizing antibodies specific for the transmembrane proteins matrix 2 and neuraminidase reduces the pulmonary virus titer but fails to clear the infection. Virology 1999; 254: 138-46.
    • (1999) Virology , vol.254 , pp. 138-146
    • Mozdzanowska, K.1    Maiese, K.2    Furchner, M.3    Gerhard, W.4
  • 21
    • 0016749432 scopus 로고
    • Host defenses against influenza virus: The role of anti-hemagglutinin antibody
    • Virelizier JL: Host defenses against influenza virus: the role of anti-hemagglutinin antibody. J Immunol 1975; 115: 434-9.
    • (1975) J Immunol , vol.115 , pp. 434-439
    • Virelizier, J.L.1
  • 22
    • 0028158626 scopus 로고
    • Protection against the mouse adapted A/FM/1/47 strain ofinfluenza A virus in mice by a monoclonal antibody with cross neutralizing activity among H1 and H2 strains
    • Okuno Y, Matsumoto KI, Isegawa Y, Ueda S: Protection against the mouse adapted A/FM/1/47 strain ofinfluenza A virus in mice by a monoclonal antibody with cross neutralizing activity among H1 and H2 strains. J Virol 1994; 68: 517-20.
    • (1994) J Virol , vol.68 , pp. 517-520
    • Okuno, Y.1    Matsumoto, K.I.2    Isegawa, Y.3    Ueda, S.4


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.